Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
Pharmaceutical giants Moderna and Merck said Wednesday that an experimental vaccine treatment has shown signs of preventing the cancer from coming back or spreading in a study of high-risk melanoma patients. The companies did not publish their results in a peer-reviewed journal or release the new data, but instead said they will be presented at … Read more